Cell therapy for Parkinson's disease: Have the glory days gone?

The Lancet Neurology

Volumn 10, Issue 6, 2011, Pages 492-493

  Albanese, Alberto ^a  

^a UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

CELL ACTIVITY; CELL THERAPY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GLIA; GRAFT SURVIVAL; HUMAN; INFLAMMATION; LETTER; NERVE STIMULATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA CELL; RETINAL PIGMENT EPITHELIAL CELL; TREATMENT OUTCOME;

ANIMALS; CLINICAL TRIALS AS TOPIC; CORPUS STRIATUM; DRUG CARRIERS; EPITHELIAL CELLS; HUMANS; PARKINSON DISEASE; RETINAL PIGMENT EPITHELIUM; SWINE; TISSUE THERAPY; TRANSPLANTATION, HETEROLOGOUS;

EID: 79956030043     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70101-6     Document Type: Letter

References (13)

1. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990, 247:574-577.
2. Cohen J New fight over fetal tissue grafts. Science 1994, 263:600-601.
3. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001, 344:710-719.
4. Hagell P, Piccini P, Bjorklund A, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002, 5:627-628.
5. Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neuotrophic factor in Parkinson disease. Nat Med 2003, 9:589-595.
6. Schumacher JM, Ellias SA, Palmer EP, et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 2000, 54:1042-1050.
7. Watts RL, Freeman TB, Hauser RA, et al. A double-blind, randomized, controlled, multicenter clinical trial of the safety and efficacy of stereotaxic intrastriatal implantation of fetal porcine ventral mesencephalic tissue (Neurocell-PD) vs imitation surgery in patients with Parkinson disease (PD). Parkinsonism Relat Disord 2001, 7(suppl):S87.
8. Gross RE, Watts RL, Hauser RA, et al. Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol 2011, the Spheramine Investigational Group, published online May 11. 10.1016/S1474-4422(11)70097-7.
9. Stover NP, Bakay RA, Subramanian T, et al. Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease. Arch Neurol 2005, 62:1833-1837.
10. Olanow CW Levodopa/dopamine replacement strategies in Parkinson's disease-future directions. Mov Disord 2008, 23(suppl 3):S613-S622.
11. Piccini P, Brooks DJ, Bjorklund A, et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999, 2:1137-1140.
12. Farag ES, Vinters HV, Bronstein J Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease. Neurology 2009, 73:1095-1102.
13. Holden C Fetal cells again?. Science 2009, 326:358-359.